Satter Management

Latest statistics and disclosures from Alerce Investment Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ANNX, AKBA, AMWL, AADI, ALRN, and represent 100.00% of Alerce Investment Management's stock portfolio.
  • Added to shares of these 1 stock: ANNX.
  • Reduced shares in these 1 stock: Assembly Biosciences.
  • Sold out of its position in Assembly Biosciences.
  • Alerce Investment Management was a net seller of stock by $-382k.
  • Alerce Investment Management has $75M in assets under management (AUM), dropping by 28.45%.
  • Central Index Key (CIK): 0001844002

Tip: Access up to 7 years of quarterly data

Positions held by Satter Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Alerce Investment Management

Alerce Investment Management holds 5 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Annexon (ANNX) 44.7 $34M +4% 7.4M 4.54
 View chart
Akebia Therapeutics (AKBA) 26.7 $20M 16M 1.24
 View chart
American Well Corp Cl A (AMWL) 20.8 $16M 11M 1.49
 View chart
Aadi Bioscience (AADI) 4.4 $3.3M 1.6M 2.02
 View chart
Aileron Therapeutics Com New (ALRN) 3.4 $2.5M 831k 3.05
 View chart

Past Filings by Alerce Investment Management

SEC 13F filings are viewable for Alerce Investment Management going back to 2020